Business Description
BeiGene Ltd
NAICS : 325412
ISIN : US07725L1026
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.45 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | -1.52 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.56 | |||||
Beneish M-Score | -2.36 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 85.3 | |||||
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 24.3 | |||||
3-Year FCF Growth Rate | 2.4 | |||||
3-Year Book Growth Rate | -7 | |||||
Future 3-5Y Total Revenue Growth Rate | 31.37 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -25.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.93 | |||||
Quick Ratio | 1.72 | |||||
Cash Ratio | 1.33 | |||||
Days Inventory | 278.18 | |||||
Days Sales Outstanding | 48.44 | |||||
Days Payable | 223.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -2.2 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 83.74 | |||||
Operating Margin % | -26.31 | |||||
Net Margin % | -25.94 | |||||
FCF Margin % | -29.58 | |||||
ROE % | -24.64 | |||||
ROA % | -15.07 | |||||
ROIC % | -34.64 | |||||
ROC (Joel Greenblatt) % | -55.89 | |||||
ROCE % | -22.26 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.74 | |||||
PB Ratio | 5.61 | |||||
Price-to-Tangible-Book | 5.7 | |||||
EV-to-EBIT | -20.9 | |||||
EV-to-Forward-EBIT | -11.26 | |||||
EV-to-EBITDA | -25.08 | |||||
EV-to-Forward-EBITDA | -11.92 | |||||
EV-to-Revenue | 5.5 | |||||
EV-to-Forward-Revenue | 4.32 | |||||
EV-to-FCF | -17.53 | |||||
Price-to-Net-Current-Asset-Value | 12.72 | |||||
Price-to-Net-Cash | 62.84 | |||||
Earnings Yield (Greenblatt) % | -4.78 | |||||
FCF Yield % | -5.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BeiGene Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 60,045.32 | ||
EPS (TTM) (MXN) | -145.982 | ||
Beta | 0.35 | ||
Volatility % | 25.95 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0.000007 | ||
20-Day SMA (MXN) | 2858.16 | ||
12-1 Month Momentum % | -25.95 | ||
52-Week Range (MXN) | 2858.16 - 3860 | ||
Shares Outstanding (Mil) | 106.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BeiGene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BeiGene Ltd Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
BeiGene Ltd Frequently Asked Questions
What is BeiGene Ltd(MEX:BGNE)'s stock price today?
When is next earnings date of BeiGene Ltd(MEX:BGNE)?
Does BeiGene Ltd(MEX:BGNE) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |